Hopital Haut Leveque

Pessac 12 trials 6 recruiting

12 Registered trials

6 Currently recruiting

Organisation

Hopital Haut Leveque

Location

Pessac, France

Identifier

ORL-000004296

Address

Avenue Magellan, 33604, France

Departments

Gastroenterology
Hematology
Hépatho-Gastroentérologie et Nutrition
Hepato-gastroenterology
Hepato-gastroenterology and digestive oncology
Hepatogastroenterology
medecine nuclear department
ONCOLOGIE
Pneumology
Pulmotension
Service d'hématologie clinique et Thérapie cellulaire

Clinical trials at this site (12)

Search interface

Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE) Pending

2024-518138-10-00 Patients with DMMR and/or MSI metastatic colorectal can 4
ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanc… Recruiting

2023-505486-92-00 Small bowel adenocarcinoma 4 2024-02-09
Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma, for evaluation of response in … Recruiting

2024-516807-17-00 Relapsing/Refractory ALK+ Anaplastic Large cell Lymphom 4 2019-01-02
Open label phase II study evaluating the efficacy and safety of the combination of tagraxofusp and venetoclax in treatment-naive blastic pla… Recruiting

2024-511003-42-00 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS 4 2025-12-11
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Relapsed/Refractory Multiple Myeloma 5 2024-05-27
STUDY TO ASSESS THE SCHEMAS OF RETREATMENT WITH LUTATHERA® IN PATIENTS WITH NEW PROGRESSION OF INTESTINAL WELL-DIFFERENTIATED NEUROENDOCRINE… Recruiting

2024-511001-28-00 Neuroendocrine tumor 4 2021-12-13
Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal (MIRACLE) Recruiting

2024-511822-30-00 Crohn’s disease 11 2021-09-22
PRODIGE 49 - OSCAR: Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 ± Irinotecan, and targeted therapy, in first… Ended

2024-518553-41-00 colon cancer and rectal with liver metastasis 5 2024-11-08
A study to evaluate the benefit and safety of Luspatercept (ACE-536) in adults with myeloproliferative neoplasm-associated myelofibrosis on … Ended

2023-507890-17-00 Anemia associated with myeloproliferative neoplasm (MPN 5 2021-02-22
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 colon cancer 4 2014-12-23
IMPACT-CTEPH Ended

2024-513672-17-00 Inoperable Chronic thromboembolic pulmonary hyperTensio 4 2021-06-14
A multicentre phase II, open-label, non-randomized study evaluating Platinum-Pemetrexed-Atezolizumab ( Bevacizumab) for patients with stage … Ended

2024-516201-23-00 Lung Cancer, NSCLC 4 2019-08-26